---
title: "Back on Track: Q121 Extremities Market Recap"
description: "The first quarter of 2021 sees a resurgence of procedures and new product introductions as M&A activity abounds,  signaling that the Extremities Market is back on track ... #extremities"
---

[Medical Device and Wound Care News and Analysis Blog ](https://blog.smarttrak.com)

# [Back on Track: Q121 Extremities Market Recap](https://blog.smarttrak.com/back-on-track-q121-extremities-market-recap)

 Written by [Lisa Mahan](https://blog.smarttrak.com/author/lisa-mahan) | 6/10/21 1:30 PM

*<https://app.smarttrak.com/analysis/qs/6d6e1280d74f8cd2ac1002ba1f627896>The first quarter of 2021 sees a resurgence of procedures and new product introductions as M&A activity abounds signaling that the Extremities Market is back on track.*

Inclement weather, the return of elective procedures and new product introductions all contributed to growth in the WW Extremities Market, up +5.1% in Q121 and the US market seeing even higher growth. M&A activity continues to impact the Extremities segment as companies expand their portfolios and work to synergize product development and commercial efforts.

Among the many topics covered in detail in our comprehensive [Q121 Extremities Market Recap](https://app.smarttrak.com/analysis/qs/6d6e1280d74f8cd2ac1002ba1f627896)* are:

- Complete Extremities Market Overview
- SmartTRAK's Expert Analysis and Insights
- M&A Changing the Shape of the Extremities Market
- Shoulders Rebounding with Elective Procedures
- Ankle Arthroplasty Changes Coming
- Extremities Fixation Back on Track
- Q121 Regulatory Highlights

Several recent acquisitions are reshaping the Extremities Market by expanding some companies’ product portfolios while giving others entry into new market segments. In Q420, [Stryker](https://app.smarttrak.com/companies/qs/9?source=smartSearch&searchData=Stryker)* completed its acquisition of Wright Medical, moving the Company above [JNJ/DePuy Synthes](https://app.smarttrak.com/companies/qs/28649?source=smartSearch&searchData=DePuy%20Synthes)* to become the US Extremities Market leader. During SYK’s Q121 earnings call, Chairman & CEO Kevin Lobo [noted](https://www.fool.com/earnings/call-transcripts/2021/04/28/stryker-corp-syk-q1-2021-earnings-call-transcript/) that ...

[**Read the entire Q121 Extremities ****Market Recap including news, data, charts, company revenues, shares and our expert analysis**](https://app.smarttrak.com/analysis/qs/6d6e1280d74f8cd2ac1002ba1f627896)*

**The entire unedited article and the links can only be viewed by *[*SmartTRAK *](https://www.smarttrak.com/)*subscribers to this module. For more information on SmartTRAK, including how to receive a demo and subscribe, please*[ click](https://www.smarttrak.com/contact-us) *the button below.*

[SmartTRAK](https://www.smarttrak.com/) has recently launched five new modules for 2021, including Pediatric Extremities, Arthroscopic Technologies, Pediatric Spine and Pediatric Trauma. Click [here](https://landing.smarttrak.com/coming-soon-for-smarttrak) to see details of all the exciting new content now available on **SmartTRAK.**

[View full post](https://blog.smarttrak.com/back-on-track-q121-extremities-market-recap)

```json
{
  "@context" : "http://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Lisa Mahan"
  },
  "dateModified" : "2021-06-10T13:30:00.728Z",
  "datePublished" : "2021-06-10T13:30:00Z",
  "headline" : "Back on Track: Q121 Extremities Market Recap",
  "image" : {
    "@type" : "ImageObject",
    "height" : 512,
    "url" : "https://f.hubspotusercontent00.net/hubfs/3044256/Q121%20Extremites%20Header%20copy.png",
    "width" : 1024
  },
  "mainEntityOfPage" : "https://blog.smarttrak.com/back-on-track-q121-extremities-market-recap",
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "height" : 60.0,
      "url" : "https://cdn2.hubspot.net/hubfs/3044256/SmartTRAK%202.0%20Logo%20Art/SmartTRAK%20Logo%20Email250.png",
      "width" : 187.5
    },
    "name" : "SmartTRAK Life Sciences News and Analysis Blog"
  }
}
```